Multiple growth factors regulate coronary embryonic vasculogenesis
Article first published online: 22 MAY 2001
Copyright © 2001 Wiley-Liss, Inc.
Volume 221, Issue 3, pages 265–273, 1 July 2001
How to Cite
Tomanek, R. J., Zheng, W., Peters, K. G., Lin, P., Holifield, J. S. and Suvarna, P. R. (2001), Multiple growth factors regulate coronary embryonic vasculogenesis. Dev. Dyn., 221: 265–273. doi: 10.1002/dvdy.1137
- Issue published online: 15 JUN 2001
- Article first published online: 22 MAY 2001
- Manuscript Accepted: 13 FEB 2001
- Manuscript Received: 10 NOV 2000
- NIH. Grant Numbers: HL 48961, HL 62178
- quail embryos;
- coronary vessels;
- heart development
Mechanisms regulating coronary vascularization are not well understood. To test hypotheses regarding the influence of key growth factors and their interactions, we studied vascular tube formation (vasculogenesis) in collagen gels onto which quail embryonic ventricles were placed and incubated in the presence of growth factors or inhibitors. Vasculogenesis in this model is dependent on tyrosine kinase receptors, since tube formation was totally blocked by genestein. Tube formation was attenuated when anti-bFGF or anti-VEGF neutralizing antibodies were added to the medium and nearly completely inhibited when the both were added. The attenuation associated with anti-VEGF was due primarily to a decrease in assembly of endothelial cells, while that associated with bFGF was primarily due to a reduction in endothelial cells. Soluble tie-2, the receptor for angiopoietins, also had an inhibitory effect and, when added with either anti-bFGF or anti-VEGF, markedly attenuated tube formation. At optimal doses, tube formation was enhanced 6.5-fold by bFGF and 2.5-fold by VEGF over the controls. Each of these growth factors was dependent upon the other for optimal induction of tube formation, since neutralizing antibodies to one markedly reduced the potency of the other. VEGF potency was also markedly reduced when soluble tie-2 was added to the medium. Tube formation was virtually totally blocked by exogenous TGF-β at doses > 1 ng/ml, while neutralizing TGF-β antibodies enhanced tube formation 2-fold in the 30 ng–30 μg range. These data provide the first documentation of multiple growth factor regulation of coronary tube formation. © 2001 Wiley-Liss, Inc.